|
Volumn 19, Issue 10, 2001, Pages 1813-1818
|
Treatment with irbesartan or atenolol improves endothelial function in essential hypertension
|
Author keywords
Angiotensin II antagonist; Blood flow; Endothelium; Human; Hypertension; Nitric oxide
|
Indexed keywords
ATENOLOL;
IRBESARTAN;
METHACHOLINE;
NITROPRUSSIDE SODIUM;
PLACEBO;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DISEASE SEVERITY;
DOUBLE BLIND PROCEDURE;
DRUG EFFECT;
ENDOTHELIUM CELL;
ESSENTIAL HYPERTENSION;
FEMALE;
FOREARM BLOOD FLOW;
HUMAN;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
VASODILATATION;
VEIN OCCLUSION PLETHYSMOGRAPHY;
|
EID: 0034809629
PISSN: 02636352
EISSN: None
Source Type: Journal
DOI: 10.1097/00004872-200110000-00015 Document Type: Article |
Times cited : (46)
|
References (39)
|